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Objwiw. This study was designed to describe the clinical 
e&is of ultrasound energy on yide+vir&nduced art&l vase. 
constriction. 
tkcbground. We have previously shown that ultrasound en. 
ergs (20 !&z) delIvered by a wire probe produces doa.drpendont, 
endothelium-independent smocth mu& relaxation capable of 
reversing both rrceptwmediated and vollagedepadent won. 
striction in vitro. 
Methods. A high intensity, tow frequency ultrasound catheter 
sy61a11 was wed to recanalizo total ~eftusions in the superficial 
femorrd arteries of two patients. After recanntieatioa, the prori. 
mal residual stenrws were each <IS%. However, distal artwial 
vasoswm w~li fobnd angiographically in a poptiteal artery ofons 
The utility of wrcutaneous (I,21 or intraoperative 13) ultra- 
sound angiophsty far atherosclerotic p&ipheral vascular 
disease has been previously reported. In the clinical setting, 
ultrasound recanzlization of total atherosclerotic occlusions 
and a reduction in arterial stenosis have been documented. 
Experimental studies in a perfused whole vessel model of 
rabbit thoracic aortas. as well as in viva studies in a canine 
model with femoral artery occlusion. have demonstrated a 
vasorelaxant effect of high intensity, low frequency (20.kHz) 
ultrasound energy (4). In this commcnication we report, for 
the first time, the clinical use of ultrasound energy to treat 
arterial vasoconstriction distal to the site of arterial recanal- 
ization. 
Methods 
Ultrasound device. In these two cases, ultrasound ener@’ 
was applied with a prototype device with an ultrasound 
frequeixy of 19.5 kHz (Baxter-Edwards LIS Division) 
patient sod in an anterior tthlal artery cd another. Subsequently, 
the ultrasound catheter probe was advanced to the sites of arterial 
vasospasm @Jiiuse in one, focal in one). 
ResuB. After 38 ,,nd 90 s, rerpeeiivety, of exposure to ultra. 
round energy with a tipqurncy of 19.5 kHz, pak tip amplitude of 
111 pm and wwer outwt at the trmtsducer ol 25 W, the 
w&pasrn w&d in each arterial went. 
Conclusions. Our Rndlngs are the first reported clinical cases 
documenlinglhat cathrterdellvered tow frequency, high intensity 
uttrasound induca arterial vasoditation atthe site of wswonstrib 
tion. These biologic etT& appear to he retattvety unique for 811 
sngioplasty device and may have ptentisl clinicat hnpotioce. 
(J Am Coil Cardial 1992;20:732-5) 
(1.2.4). The paver output at the acoustic horn was 25 W 
used in a pulsed mode with a501 duty cycle of30ms onand 
30 ms oIf. The portable generator operates at I I5 V altemat- 
ing current and weighs 7 kg. The ultrasound energy was 
transmitted bv a 9Q.cm low flexible 0.030.in. <O.@Scm) 
tapering to 0.020-in. (0.05.cm) solid titanium wire with a 
3.mm hall-tipped probe. The titanium wire is ensheathed in a 
7F catheter. The probe tip has B channel to permit passage 
over a O.MS-in. (0.06.cm) guide wire in a monorail fashion. 
With a25-W power output at theacoustic horn. the probe tip 
peak to peak longitudinal displacements are approximately 
I I I pm as measured by an optical microscope. The acceler- 
ations at the probe tip range up to 82,MQ g. During applica- 
tion of ultrasound energy, normal saline solution war infused 
at a rate of 0.5 mlls to prevent heating of the probe. 
Case Reports 
Case 1. This patient is a 7byear old woman with a history 
of 75-m claudication. On physical examination, the right 
dorsalis pedis and posterior tibia1 pulses were not palpable. 
After local lidccaine analgesia, a 9F arterial sheath war 
placed in an anterograde direction i the ipsilateral super6 
cial femoral artery by percutaneous catheterization using the 
Seldinger technique. Three thousand units of intraafierial 
heparin was given. Angiography was performed with iox- 
aglate contrast medium and revealed a S-cm total occlusion 
of the distal right femoral artery. The total occlusion WBE 
subsequently crossed with an 0.0X5-in. (0.Of&cm) Temmo 
energy rewlted in rec*“alilPtion of 
a totally occluded left superficial 
hmra1 anery. DiRuse plsm Of 
the anterior thial artery Carmxrl 
is demonstrated. B. Ultrasound 
catheter probe Up and guide wire 
wrow, Pcross the Libird anery. 
C. Arterial vasodiladon and reso- 
lution of the tibia1 vasospasm atier 
30 s of exposure to catbeter- 
delivered ultrasaund energy ,fre- 
quency 19.5 kHz). 
guide wire. Subsequently. the energized prototype over the 
wire 3.mm ball-tipped ultrasound probe-catheter system was 
advanced across the lesion. During application of ultrasound 
energy. the probe was advanced in steps of 2 to 3 mm per 
IS s. After auulication of the ultrasound probe alone for 
4.5 min. the &dual stenosis was <IO% and a small diseec- 
lion was present at the site of orior total occlusion. Distal to 
the site of recanalizntion. there was vasoconstriction in a 
previously angiographically nomtal-appeanng anterior tibia1 
artery (Fig. IA). The guide wire was then advanced across 
the vasospastic segment (Fig. IB) over which the activated 
ultrasound probe was passed. After 30 s oi application of 
ultrasound energy with a power output of 25 W at the 
acoustic ham >nd a probe tip peak to peak displacement of 
III pm, the anterior tibial vasoconstriction resolved with no 
further detectable lumen narrowing (Fig. 10. After the 
procedure, no distal emboli were detected angiographically 
and both dorsalis pedis and posterior tibial arterial pulses 
became palpable. 
Case 2.“he patient is B G-year old man with 8O.m 
claudication. On physical examination. the right posterior 
tibia1 artery was faintly palpable. As in Case I. after 
lidocaine analgesia a 9F introducer was placed in an an- 
terogradc direction in the ipsilateral (right) femornl anery by 
percutaneous catheterization using the Seldinger technique 
and 3,000 U of heparine was given intraarterially. Angiogra- 
phy with ioxaglate contrast medium demonstrated an ap- 
proximately 4.cm total occlusion of rhe distal supeficial 
femoral artery. A 0.025-in. Terumo guide wire WBE used 
to cross the lesion and the energized 3.mm ball-tipped. 
over the wire prototype ultrasound probe was used to 
effectivsly recanalize the artety at a rate of 2 to 3 mm/IS-s 
intervals over a total duration of 4 min. The residud 
diameter stemxis wns <I%% Subsequent angiography 
showed focal vasoconstriction in the popliteJ xtery 
distal to the rite of arterial recanaliwtion (Fig. ?A). The 
over the wire probe system was then advanced to rhe we of 
focal vasoconsrriction and 2S-W ultrasound energy. 8s mea- 
sured from the xoustic horn. was applied for a total of 90 s. 
The vasoconstnction resolved after the application of ultra- 
sound energy IFig 2B). Postprocedure angio&pby of the 
distal vasculature did not reveal any further areas of vasw 
constriction or evidence of distal embolization. On physical 
examination the posterior tibisl artery pulse wus readily 
palpable. 
Discussion 
Comparison with previws shtd&. The findings in these 
two pntients demonstrate that the application of catheter- 
delivered ultrasound energy induces anerial vasodilation at 
the site of vasxonatriction. These findings are in contradir- 
tinction to the effects of balloon angioplasty (5). “hot-lip” 
thermal and some continuous wave lasers (6-8). as well as 
the Rotablator (9.10). which may result in arterial v~socon- 
striction and Row reduction with the potential for promoting 
distal &hernia. Of note, no premeditation with nitrates. 
calcium channel blockers or other vasodilating agents was 
given to prevent wsoconstriction during the rmgiwlasty 
procedure. No vasodilating pharmacologic interventiotl was 
given after the recognition of distal vasospasm because our 
prior enpetimental data indicated that ultesound energy is a 
potent arterial vascdilator. 
Fischell et al. (4) showed with a similar ult asound system 
and energy levels that ultrasound energy results in vasodi- 
lation that reverses both voltage-dependent and receptor- 
mediated vasoconstriction. These findings were demon- 
strated in vitro in rabbit aortas as well BS in viva in a canine 
model with long-term occlusion of the superficial femoral 
dtiery. To test the effect on receptor-mediated vavxonstric- 
A B 
Figure 2. Case 2. A. Angiogram after catheter-delivered 
ultrasound energy resulted in rccanalization fa totally 
occluded left supcrficiai Femoral rtery. Pocal spasm of 
the popliteal ancry is demonstrated (arrowL B, Resolu- 
tion MO*) of vawspasm after application of 90 s of 
ca,he,er-dclivcrcd “llrasound energy. 
lion. thoracic rabbit aortas in a perfused whole vessel model 
underwent pr~orcontraction with phenylephrine. Ultrasound 
energy, in the doses administered to the patients in this 
report. caused dose-dependent relaxation in the prccon- 
tracted rabbit aortas. This relaxation occurred in intact 
aonas and m aonttr that were in!entionally deendothelialized 
before exposure to ultrasound rncqy. in similar experi- 
mcnts using voltage-dependent prccontraction of the tho- 
racic aortas with potassium chloride, ultrasound also caused 
significant local vasodilation. In the in vitro model. tempcr- 
alure measurements howed a <I”C warming of the vessel 
wall during up to 2 min of exposure to :dfrasound, thus 
excluding B thermal mechanism for vasodilation. In aa in 
viva canine model with B long-term total occlusion and 
subsequent rccanaliration, focal application of ultrasound 
resulted in arterial relaxation at a site of vasoconstriction 
that was distal to the area of recanalization. In neither the 
rabbit aortas nor the canine model was there histolcgic 
evidence by light or elec’ron microscopy to implicate ther- 
mal effects or irrcverrihle smooth muscle cell injury at 
moderate ultrasound energy levels (4). 
iResent casts and mechanism of ultrasound~indueed wso- 
dilation. In the two clinical cases at the sites of vasocoo- 
striction and subsequent arterial relaxation induced by ultra- 
sound. there was no evidence of injury to the arterial wall ns 
manifested by dissection, aneu:ysm or staining by angio- 
graphic contrast medium. In neither case was the patient 
pretrea!ed with vasudilators. nor were vasodilators admin- 
istered to attempt to resolve the distal arterial vaaospasm so 
that no comparison of therapies can be made. In addition, no 
experimental or clinical data are available on whether ultra- 
smmd energy is effective in drug-resistant vasoconstriction. 
The mechanism of ultrasound-induced vasodilation remains 
speculative in the in vitro as well as the in viva setting. 
Vasodilation does not appear to be related to the release of 
endothclium-derived relaxing factor or other endothelium- 
derived substances from the arachidonic acid cascade 
such as prostacyclin (4). Histopathologic data from in 
vitro and in viva animal studies document that neither 
vascular injury nor thermal effects are responsible for 
ultrasound-induced vasodilation. The use of ultrasound en- 
ergy in the 20.kHz frequency range is standard laboratory 
technique in cell biology to reversibly fragment actin fila- 
ments. Thus, as hypothesized by Fischell et al. (5). rcvers- 
ible actin filament disruption could explain ultrasound- 
mediated smooth muscle cell relaxation, although one 
cotdd not exclude disruption of other structural components 
of the smooth muscle cells’ contractile apparatus or, with 
high power outputs, of ultrasound smooth muscle cell lysis 
itself. 
Conclusions. The two eases presented demonstrate a 
vasodilator effect of low frequency (195kHzL high intensity 
ultrasound energy in humans in viva These findings are 
consistent with data from prior experimental in vitro 
and in viva animal studies (4). These biologic effects of 
catheter~delivcred ultrasound appear to be relatively 
unique for INI angioplasty device. The ultimate clinical 
importance of ultrasound-mediated vasorclaxation remains 
to be tested. 

